Vor Biopharma (VOR) Research & Development (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Research & Development data on file, last reported at $17.6 million in Q1 2026.

• On a quarterly basis, Research & Development fell 34.1% year-over-year to $17.6 million in Q1 2026; TTM through Mar 2026 was $312.4 million, a 226.5% increase from a year earlier, with the FY2025 full-year figure at $321.5 million, up 244.58% from the prior year.
• Research & Development for Q1 2026 stood at $17.6 million, down from $19.2 million in the prior quarter.
• Over the last five years, Research & Development for VOR reached as high as $261.5 million in Q2 2025 and fell as low as $14.1 million in Q3 2025.
• Historically, Research & Development has averaged $34.8 million across 5 years, with a median of $21.8 million in 2024.
• On a YoY basis, Research & Development climbed as much as 1098.27% in 2025 and fell as far as 35.18% in 2025.
• Year by year, Research & Development stood at $17.1 million in 2022, then gained by 22.48% to $20.9 million in 2023, then grew by 21.3% to $25.3 million in 2024, then dropped by 24.29% to $19.2 million in 2025, then slipped by 8.31% to $17.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $17.6 million in Q1 2026, $19.2 million in Q4 2025, and $14.1 million in Q3 2025.